Morpho (MORPHO) is currently priced at $1.75, reflecting a 6.36% decline over the last 24 hours. The daily trading range has been relatively narrow, fluctuating between a high of $1.87 and a low of $1.71, indicating limited volatility in the short term.

Volume stands at approximately 30.37 million, with a volume-to-market cap ratio of 3.15%, suggesting moderate trading activity relative to its market capitalization. The hourly moving averages indicate a bearish trend, with the 8, 13, and 21 SMA all showing declines of 3.38%, 3.06%, and 2.92% respectively, while the 55 SMA shows a sharper drop of 4.69%.

In contrast, the 144 SMA shows a slight increase of 1.68%, suggesting potential support around $1.72. The 1-hour RSI is currently at 36, indicating oversold conditions, while the 7-day RSI at 53 points to a more neutral sentiment.

On a longer-term basis, the 7-day price change is 10.77%, and both the 14-day and 30-day price changes are robust at 42.87% and 46.16%, respectively, indicating strong upward momentum in recent weeks. However, the current price remains significantly below its all-time high of $4.17, set in January 2025.

Given the recent price decline and the bearish signals from the moving averages, it is advisable to adopt a cautious approach. Despite the bullish longer-term trends, the current technical indicators suggest potential downside risk.

Rating: Hold. The short-term bearish trends warrant caution, while the strong long-term performance indicates potential for recovery; thus, maintaining current positions without initiating new buys is prudent.